0001179110-17-014313.txt : 20171117 0001179110-17-014313.hdr.sgml : 20171117 20171117163221 ACCESSION NUMBER: 0001179110-17-014313 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171115 FILED AS OF DATE: 20171117 DATE AS OF CHANGE: 20171117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LYNCH DANIEL CENTRAL INDEX KEY: 0001177082 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37359 FILM NUMBER: 171211405 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Blueprint Medicines Corp CENTRAL INDEX KEY: 0001597264 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 38 SIDNEY STREET, SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-374-7580 MAIL ADDRESS: STREET 1: 38 SIDNEY STREET, SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 edgar.xml FORM 4 - X0306 4 2017-11-15 0 0001597264 Blueprint Medicines Corp BPMC 0001177082 LYNCH DANIEL C/O BLUEPRINT MEDICINES CORPORATION 38 SIDNEY STREET, SUITE 200 CAMBRIDGE MA 02139 1 0 0 0 Common Stock 2017-11-15 4 S 0 1600 64.15 D 207742 D Common Stock 2017-11-15 4 S 0 2200 63.25 D 205542 D Common Stock 2017-11-15 4 S 0 1200 62.59 D 204342 D The sales reported on this Form 4 were effected pursuant to a trading plan adopted on December 20, 2016 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.79 to $64.77 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (4) to this Form 4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.79 to $63.75 per share. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.33 to $62.74 per share. /s/ Christopher Frankenfield, Attorney-in-Fact 2017-11-17